SynthesisClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2026
Global Prevalence of Sexual Dysfunction in Individuals With Atopic Dermatitis and Asthma: A Systematic Review and Meta-Analysis.
Synthesis in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveAsthma and atopic dermatitis are associated with various physical and psychosocial outcomes, however, the prevalence of sexual dysfunction in these populations remains underexplored. This meta-analysis aimed to assess the prevalence of sexual dysfunction among individuals with asthma and atopic dermatitis.
designA systematic review and random-effects meta-analysis was conducted to estimate pooled prevalence with 95% confidence intervals (CIs). Subgroup analyses were conducted stratifying by sex, geographic regions and diagnostic tools. DATA SOURCES: PubMed/MEDLINE, Embase, Scopus and Cochrane Library were searched from inception to 1 July 2025. ELIGIBILITY CRITERIA: Studies including adults with asthma or atopic dermatitis were eligible. Sexual dysfunction was defined as impairments in sexual desire or sexual response, identified via clinical diagnosis or validated questionnaires, including the Female Sexual Function Index and International Index of Erectile Function.
resultsA total of 19 studies comprising 10,851 participants, including 1577 patients with asthma or atopic dermatitis from 18 countries across five continents, were included. The pooled prevalence of sexual dysfunction was 54.3% (95% CI 45.9-64.3) in asthma and 19.1% (13.4-27.3) in atopic dermatitis. In both conditions, prevalence was substantially higher in females than males: 71.5% (95% CI 63.3-80.7) versus 29.6% (17.1-51.2) in asthma and 53.0% (36.4-77.1) versus 16.7% (7.3-38.2) in atopic dermatitis. Studies using validated tools reported higher prevalence than those relying on supportive methods or clinical diagnoses. Smoking status was not significantly associated with differences in prevalence among individuals with asthma. Among control groups, pooled prevalence was 9.7% (95% CI 0.6-169.6) for males and 30.1% (18.7-48.5) for females in asthma studies and 2.2% (0.16-28.8) overall in atopic dermatitis studies.
conclusionsSexual dysfunction was highly prevalent among individuals with asthma and atopic dermatitis, particularly in females. These findings highlight the need for greater clinical attention to sexual dysfunction in the management of allergic diseases. SYSTEMATIC REVIEW REGISTRATION: PROSPERO (CRD420251115928).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.